Literature DB >> 25821083

Comparison of higher energy collisional dissociation and collision-induced dissociation MS/MS sequencing methods for identification of naturally occurring peptides in human urine.

Martin Pejchinovski1,2, Julie Klein2, Adela Ramírez-Torres2, Vasiliki Bitsika3, George Mermelekas3, Antonia Vlahou3, William Mullen4, Harald Mischak2,4, Vera Jankowski5.   

Abstract

PURPOSE: The aim of this study is to determine the best fragmentation method for sequence identification of naturally occurring urinary peptides in the field of clinical proteomics. EXPERIMENTAL
DESIGN: We used LC-MS/MS analysis of urine samples to determine the analytical performance of higher energy collisional dissociation (HCD), CID with high and low resolution MS/MS for the identification of naturally occurring peptides in the low molecular weight urinary proteome.
RESULTS: HCD and CID high-resolution generated a 22% error rate in peptide sequence identifications. CID low-resolution showed significantly higher error rates (37%). Excluding the error rate (i.e rejection of cysteine-containing peptides), we observed a higher degree of overlap between HCD and CID high resolution for identification of peptide sequences of rank 1 and cross-correlation ≥ 1.9 (262 peptide sequences) compared to CID low (208 peptide sequences with HCD and 192 peptide sequences with CID high). Reproducibility of detected peptides in three out of the five replicates was also higher in HCD and CID high in relation to CID low resolution. CONCLUSION AND CLINICAL RELEVANCE: Our data demonstrated that HCD and CID high-resolution performed with better accuracy and reproducibility than CID low resolution in respect to the identification of naturally occurring urinary peptide sequences.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biomarkers; Clinical proteomics; MS/MS sequencing; Peptide fragments

Mesh:

Substances:

Year:  2015        PMID: 25821083     DOI: 10.1002/prca.201400163

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  8 in total

1.  Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus.

Authors:  M Pejchinovski; J Siwy; W Mullen; H Mischak; M A Petri; L C Burkly; R Wei
Journal:  Lupus       Date:  2017-05-05       Impact factor: 2.911

Review 2.  Urine Proteomics in the Era of Mass Spectrometry.

Authors:  Ashley Beasley-Green
Journal:  Int Neurourol J       Date:  2016-11-22       Impact factor: 2.835

3.  Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?

Authors:  Pedro Magalhães; Martin Pejchinovski; Katerina Markoska; Miroslaw Banasik; Marian Klinger; Dominika Švec-Billá; Ivan Rychlík; Merita Rroji; Arianna Restivo; Giovambattista Capasso; Flaviu Bob; Adalbert Schiller; Alberto Ortiz; Maria Vanessa Perez-Gomez; Pablo Cannata; Maria Dolores Sanchez-Niño; Radomir Naumovic; Voin Brkovic; Momir Polenakovic; William Mullen; Antonia Vlahou; Petra Zürbig; Lars Pape; Franco Ferrario; Colette Denis; Goce Spasovski; Harald Mischak; Joost P Schanstra
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

Review 4.  Short overview on metabolomic approach and redox changes in psychiatric disorders.

Authors:  Gordana Nedic Erjavec; Marcela Konjevod; Matea Nikolac Perkovic; Dubravka Svob Strac; Lucija Tudor; Coral Barbas; Tilman Grune; Neven Zarkovic; Nela Pivac
Journal:  Redox Biol       Date:  2017-09-06       Impact factor: 11.799

5.  Production of alkaline pectinase: a case study investigating the use of tobacco stalk with the newly isolated strain Bacillus tequilensis CAS-MEI-2-33.

Authors:  Ge Zhang; Shugui Li; Yingbo Xu; Juan Wang; Fan Wang; Yuhua Xin; Zhong Shen; Haibo Zhang; Ming Ma; Haobao Liu
Journal:  BMC Biotechnol       Date:  2019-07-12       Impact factor: 2.563

6.  Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial.

Authors:  Wilfried Gwinner; Annika Karch; Jan H Braesen; Abedalrazag A Khalifa; Jochen Metzger; Maarten Naesens; Elisabet Van Loon; Dany Anglicheau; Pierre Marquet; Klemens Budde; Mareen Matz; Wolfgang Arns; Michael Fischereder; Antje Habicht; Ute Eisenberger; Anja Mühlfeld; Martin Busch; Michael Wiesener; Irina Scheffner; Armin Koch
Journal:  Transplant Direct       Date:  2022-04-12

7.  Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis.

Authors:  Agnieszka Latosinska; Konstantinos Vougas; Manousos Makridakis; Julie Klein; William Mullen; Mahmoud Abbas; Konstantinos Stravodimos; Ioannis Katafigiotis; Axel S Merseburger; Jerome Zoidakis; Harald Mischak; Antonia Vlahou; Vera Jankowski
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

8.  Dual mTOR/PI3K inhibition limits PI3K-dependent pathways activated upon mTOR inhibition in autosomal dominant polycystic kidney disease.

Authors:  Yang Liu; Martin Pejchinovski; Xueqi Wang; Xuebin Fu; Deborah Castelletti; Terry J Watnick; Alexandre Arcaro; Justyna Siwy; William Mullen; Harald Mischak; Andreas L Serra
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.